Based on this YouTube video's total view count of 307 views and industry-standard rates, the estimated total earning is $0 - $1 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Starpharma (ASX:SPL, US OTC:SPHRY): Building the future of biotech in the age of AI with 307 views, 0 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.

As AI transforms drug discovery and development, the opportunity to harness new technology while keeping patients, scientific outcomes and long-term shareholder value at the centre is evolving. Starpharma (ASX:SPL, US OTC:SPHRY) is advancing its dendrimer technology across areas including oncology while navigating this rapidly changing biotech landscape. Ahead of presenting at Australian Shareholders’ Association Investor Summit - Future fortunes, human edge, investing in the age of AI - Starpharma Chief Executive Officer, Cheryl Maley, joins Lel Smits from The Stock Network to discuss the opportunities in AI use in drug development and biotechnology. 1. Biotech in the age of AI AI is rapidly changing drug discovery and development. Where do you see the biggest opportunities for AI in biotech, and where does human expertise remain critical? 2. Keeping patients and shareholders at the centre As technology moves quickly, how do you ensure the focus remains on delivering better outcomes for patients while creating sustainable, long-term shareholder value? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.